Find clinical trials for Adenocarcinoma in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma

Cancer

Pancreatic Cancer

Colorectal Cancer

Stomach Cancer

Esophageal Cancer

Prostatic Cancer

Adenocarcinoma trials near Seattle, WA, USA:

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma...

Enrolling

Locally Advanced Pancreatic Adenocarcinoma

Borderline Resectable Pancreatic Adenocarcinoma

Drug: PTM-101

Phase 1

PanTher Therapeutics

Seattle, Washington, United States and 3 other locations

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...

Enrolling

Advanced Adenocarcinoma

Drug: BA3182

Phase 1

BioAtla

Seattle, Washington, United States and 8 other locations

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) (TroFuse-015)

(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...

Enrolling

Gastroesophageal Cancer

Drug: Rescue medication

Drug: Supportive care measures

Phase 3

Merck Sharp & Dohme (MSD)

Seattle, Washington, United States and 165 other locations

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PRISM-1)

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...

Enrolling

Metastatic Pancreatic Ductal Adenocarcinoma

Drug: Gemcitabine

Drug: Nab-paclitaxel

Phase 3

Arcus Biosciences

Seattle, Washington, United States and 96 other locations

Locations recently updated

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 302)

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Enrolling

PDAC - Pancreatic Ductal Adenocarcinoma

PDAC

Drug: 5-fluorouracil

Drug: leucovorin

Phase 3

Revolution Medicines

Seattle, Washington, United States and 57 other locations

FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer

The purpose of this study is to find out if an experimental drug will prevent metastatic pancreatic adenocarcinoma from becoming resistant t...

Enrolling

Pancreatic Adenocarcinoma Metastatic

Pancreatic Adenocarcinoma

Drug: FOLFIRNINOX

Drug: 9-ING-41

Phase 2

Colin D. Weekes, M.D., PhD

Seattle, Washington, United States and 2 other locations

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

adenocarcinoma (GEA), biliary tract cancer (BTC), or colorectal cancer (CRC)....

Active, not recruiting

HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Drug: Oxaliplatin

Drug: Fluorouracil

Phase 2

Jazz Pharmaceuticals

Seattle, Washington, United States and 22 other locations

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection comp...

Begins enrollment in 1 month

Metastatic Gastric Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma

Drug: 5-fluorouracil (5-FU)

Drug: Cisplatin

Phase 3

BeiGene

Tacoma, Washington, United States and 86 other locations

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

T-cells in Subjects with Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma...

Enrolling

Esophageal Cancer

Gastric Cancer

Biological: LB1908

Phase 1

Legend Biotech

Seattle, Washington, United States and 7 other locations

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body (STAR-221)

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting

Advanced Upper Gastrointestinal Tract Adenocarcinoma

Drug: Domvanalimab

Drug: Zimberelimab

Phase 3

Arcus Biosciences

Seattle, Washington, United States and 210 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Adenocarcinoma in .css-epvm6{white-space:nowrap;}Seattle, WA

Related conditions:

Adenocarcinoma trials near Seattle, WA, USA:

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) (TroFuse-015)

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PRISM-1)

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 302)

FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body (STAR-221)

Find clinical trials for Adenocarcinoma in Seattle, WA